CABA SCHEDULE 13G/A: SEC filing
Bain Capital Life Sciences Opportunities III, LP
Filed with the SEC on · accession 0001193125-26-461980
CABA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -13.3% by the first close after the filing.
Summary of the filing
Bain Capital Life Sciences Opportunities III, LP filed an amended Schedule 13G reporting beneficial ownership of 21,209,188 shares of Cabaletta Bio common stock (including 6,000,000 shares underlying a pre-funded warrant), representing 9.57% of the outstanding shares as of September 30, 2026.
Key details
How CABA stock reacted
Close before
$1.28
Nov 13, 2026
First close after
-13.28%
$1.11
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CABA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CABA?
Click hereFrequently asked questions
What did CABA file with the SEC on Nov 16, 2026?
CABA filed a SCHEDULE 13G/A (SEC filing). Bain Capital Life Sciences Opportunities III, LP filed an amended Schedule 13G reporting beneficial ownership of 21,209,188 shares of Cabaletta Bio common stock (including 6,000,000 shares underlying a pre-funded warrant), representing 9.57% of the outstanding shares as of September 30, 2026.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CABA stock react to this filing?
CABA closed at $1.28 before the filing and $1.11 on Nov 16, 2026 (-13.28%).
Other CABA SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 12, 2026
- 8-K · Fda approvalNov 9, 2026
- SCHEDULE 13G/A · SEC filingNov 6, 2026
- SCHEDULE 13G/A · SEC filingNov 6, 2026
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingOct 30, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · SEC filingSep 14, 2026
Get alerts when CABA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days